Core Insights - Nanobiotix is a late-stage clinical biotechnology company focused on pioneering nanotherapeutic approaches for cancer and other major diseases [1][2][3] - The company will participate in a fireside chat at the Jefferies London Healthcare Conference on November 17, 2025, featuring CEO Laurent Levy and CFO Bart van Rhijn [1] - Nanobiotix is headquartered in Paris, France, and is listed on Euronext Paris and Nasdaq, with subsidiaries in Cambridge, Massachusetts [3] Company Overview - Nanobiotix was incorporated in 2003 and has been listed on Euronext Paris since 2012 and on Nasdaq since December 2020 [3] - The company holds over 25 patent families related to three nanotechnology platforms, which have applications in oncology, bioavailability and biodistribution, and central nervous system disorders [3] Upcoming Events - The fireside chat will be held on November 17, 2025, at 3pm GMT / 10am ET / 4pm CET, and will be webcast live [1] - A replay of the webcast will be available after the event [1]

Core Insights - Profound Medical Corp has entered an exclusive distribution agreement with Al Faisaliah Medical Systems Co for its TULSA-PRO and Sonalleve technologies in Saudi Arabia, facilitating access to the Middle East healthcare market [1][6] Company Overview - Profound Medical Corp is a commercial-stage medical device company specializing in AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue [9] - The company focuses on two main products: TULSA-PRO for prostate disease and Sonalleve for uterine conditions [4][11] Product Details - TULSA-PRO is designed for treating prostate diseases, utilizing MRI guidance and ultrasound to heat tissue to 'kill temperature' (55-57°C) without incisions or radiation [3][10] - Over 4,000 men have undergone the TULSA Procedure, with 67 TULSA-PRO systems installed as of October 2025 [3] - Sonalleve is primarily sold as a one-time capital sale and is gaining traction outside the U.S., with ten devices operational in Europe, China, and Southeast Asia, treating over 4,000 women for conditions like adenomyosis and uterine fibroids [4][11] Market Strategy - The company is deploying a direct sales team in North America while partnering with strategic distributors globally to enhance market penetration [5] - The partnership with Al Faisaliah Medical Systems is expected to leverage their expertise in introducing advanced medical technologies in Saudi Arabia [6][7] Regulatory and Reimbursement Updates - The U.S. Centers for Medicare & Medicaid Services established reimbursement for the TULSA procedure under the outpatient prospective payment system, effective January 1, 2025 [3] - TULSA-PRO has received necessary regulatory approvals, including CE marking, Health Canada approval, and FDA clearance [10]

CINCINNATI, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Executives from The E.W. Scripps Company (NASDAQ: SSP) will discuss the company’s business strategies at three investor conferences in November and December. Wells Fargo TMT SummitDate: Tuesday, Nov. 18Fireside chat: 3 p.m. PT / 6 p.m. ETCompany executives: Jason Combs, CFO, and Carolyn Micheli, EVP, investor relations Bank of America Securities Leveraged Finance ConferenceDate: Tuesday, Dec. 2Presentation: 8:50 a.m. ETCompany executives: Jason Combs, CFO, and B ...

LITTLE ROCK, Ark., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its Chief Financial Officer & Treasurer, Paul Bullington, and Senior Vice President, Investor Relations and Treasury, Bill DiTullio, are scheduled to present at the Wells Fargo 9th Annual TMT Summit. The presentation is scheduled for 9:30 AM PST / 12:30 PM EST on November 18, 2025 in Rancho Palos Verdes, CA. You may access a live webcast of the event on Uniti’s Investor Relations website at in ...

BURLINGTON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Burlington Stores, Inc. (NYSE: BURL), a nationally recognized off-price retailer of high-quality, branded apparel, footwear, accessories, and merchandise for the home at everyday low prices, will release its third quarter fiscal year 2025 results before the U.S. stock market opens on Tuesday, November 25, 2025. The Company will also hold a conference call to discuss results at 8:30 a.m. (Eastern Time) that day. The U.S. toll free dial-in for the conference ...

HOUSTON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Evolution Petroleum Corporation (NYSE American: EPM) ("Evolution" or the "Company") today announced its financial and operating results for its fiscal first quarter ended September 30, 2025. Evolution also declared its 14th consecutive $0.12 cash dividend per common share, payable on December 31, 2025, marking its 49th consecutive quarterly cash dividend payment. Financial & Operational Highlights ($ in thousands) Q1 2026 Q1 2025 Q4 2025 % Change vs Q1/Q1 % Change ...

ORLANDO, Fla., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Innventure, Inc. (NASDAQ: INV) (“Innventure”), an industrial growth conglomerate, today announced it will release its third quarter 2025 financial results after market close on Thursday, November 13, 2025. Management will host a conference call on the day of the release (November 13, 2025) at 5:00 pm ET to discuss the results. The event will be webcasted live via our investor relations website https://ir.innventure.com/ or via this link. Parties interested in ...

Total Revenue Growth of 24.2% Year Over Year Same Store Sales Growth of 10.8% Year Over Year Opened 11 New Stores in the Third Quarter SCOTTSDALE, Ariz., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Black Rock Coffee Bar, Inc. (Nasdaq: BRCB) (“Black Rock Coffee Bar” or the “Company”) today announced financial results for the third quarter ended September 30, 2025. “Black Rock Coffee Bar delivered exceptional third quarter results, with strong revenue performance underpinned by robust same store sales growth of 10.8% a ...

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced today that Michael Castagna, Chief Executive Officer, and Chris Prentiss, Chief Financial Officer, are scheduled to present and share updates during the Jefferies London Healthcare Conference on Wednesday, November 19, at 6:30 am ET/11:30 am GMT. The link to the live audio webcast of the session is available on MannKind Corporation’s website at: https://investors.mannkindcorp.com/even ...

DENVER, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (the "Company" or "CPH") wholly-owned subsidiary Brundage-Bone Concrete Pumping, Inc. (“Brundage-Bone”), a leading provider of concrete pumping services based in the U.S., has completed the acquisition of C.G.A. Concrete Pumping Ltd.(“CGA”), based in Cork, Republic of Ireland. This acquisition marks an exciting step in Brundage-Bone’s international expansion and ongoing investment strategy. CGA has built a strong reputa ...